The Transplant Company announced that it has submitted its comment letter in response to the draft Local Coverage Determination, LCD, related to molecular testing for solid organ transplant rejection.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDNA:
- Hold Rating for CareDx Amid Revenue Uncertainties and Valuation Discount
- CareDx initiated with a Market Perform at William Blair
- Cathie Wood Buys $172M Worth of Bullish Stock (BLSH) on Blockbuster IPO Debut, Trims Stake in SHOP
- CareDx price target lowered to $22 from $26 at BTIG
- CareDx Inc. Reports Strong Growth Amid Challenges